Sarepta Therapeutics Long Term Deferred Assets (Quarterly) Insights

Sarepta Therapeutics, Inc. (SRPT)

18.88 +0.29 (+1.56%) USD | NASDAQ | Feb 20, 16:00

18.58 -0.30 (-1.59%) After-Hours: 20:00

View Long Term Deferred Assets (Quarterly) for SRPT.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Assets (Quarterly) Benchmarks

Start Trial

Arrowhead Pharmaceuticals, Inc.	--
Merck & Co., Inc.	--
Pfizer Inc.	Upgrade
REGENXBIO, Inc.	--
Keros Therapeutics, Inc.	--